Commentary on "Health economics and the value of therapy in Alzheimer's disease." Cholinesterase inhibitors in Alzheimer's disease--evidence-based or evidence-biased?
Lanctôt
Krista L
KL
Psychopharmacology Research Program and Department of Psychiatry, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Ontario, Canada. krista.lanctot@sunnybrook.ca
Herrmann
Nathan
N